Frequency Therapeutics FREQ Stock
Frequency Therapeutics Price Chart
Frequency Therapeutics FREQ Financial and Trading Overview
| Frequency Therapeutics stock price | 0.3 USD |
| Previous Close | 0.38 USD |
| Open | 0.37 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 1200 |
| Day's Range | 0.37 - 0.4 USD |
| 52 Week Range | 0.35 - 5.59 USD |
| Volume | 38.94K USD |
| Avg. Volume | 208.02K USD |
| Market Cap | 13.44M USD |
| Beta (5Y Monthly) | 0.633039 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
FREQ Valuation Measures
| Enterprise Value | -13165761 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.27437955 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.25245133 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.183 |
Trading Information
Frequency Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.633039 |
| 52-Week Change | -65.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.59 USD |
| 52 Week Low | 0.35 USD |
| 50-Day Moving Average | 0.39 USD |
| 200-Day Moving Average | 1.69 USD |
FREQ Share Statistics
| Avg. Volume (3 month) | 208.02K USD |
| Avg. Daily Volume (10-Days) | 118.25K USD |
| Shares Outstanding | 35.75M |
| Float | 34.6M |
| Short Ratio | 5.87 |
| % Held by Insiders | 7.83% |
| % Held by Institutions | 21.18% |
| Shares Short | 698.59K |
| Short % of Float | 2.08% |
| Short % of Shares Outstanding | 1.94% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.22% |
| Return on Equity (ttm) | -93.70% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -42015000 USD |
| EBITDA | -72045000 USD |
| Net Income Avi to Common (ttm) | -77737000 USD |
| Diluted EPS (ttm) | -2.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 66.65M USD |
| Total Cash Per Share (mrq) | 1.86 USD |
| Total Debt (mrq) | 39.97M USD |
| Total Debt/Equity (mrq) | 75.06 USD |
| Current Ratio (mrq) | 3.144 |
| Book Value Per Share (mrq) | 1.489 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -55026000 USD |
| Levered Free Cash Flow (ttm) | -25457000 USD |
Profile of Frequency Therapeutics
| Country | United States |
| State | MA |
| City | Lexington |
| Address | 75 Hayden Avenue |
| ZIP | 02421 |
| Phone | 781 315 4600 |
| Website | https://www.frequencytx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, and The Scripps Research Institute. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Q&A For Frequency Therapeutics Stock
What is a current FREQ stock price?
Frequency Therapeutics FREQ stock price today per share is 0.3 USD.
How to purchase Frequency Therapeutics stock?
You can buy FREQ shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Frequency Therapeutics?
The stock symbol or ticker of Frequency Therapeutics is FREQ.
Which industry does the Frequency Therapeutics company belong to?
The Frequency Therapeutics industry is Biotechnology.
How many shares does Frequency Therapeutics have in circulation?
The max supply of Frequency Therapeutics shares is 36.52M.
What is Frequency Therapeutics Price to Earnings Ratio (PE Ratio)?
Frequency Therapeutics PE Ratio is 0.00000000 now.
What was Frequency Therapeutics earnings per share over the trailing 12 months (TTM)?
Frequency Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Frequency Therapeutics company belong to?
The Frequency Therapeutics sector is Healthcare.
Frequency Therapeutics FREQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}